Effect of Remdesivir on mortality and length of stay in hospitalized COVID-19 patients: A single center study

被引:7
作者
Shaikh, Quratulain [1 ]
Sarfaraz, Samreen [1 ]
Rahim, Anum [2 ]
Hussain, Mujahid [3 ]
Shah, Rabeea [1 ]
Soomro, Sara [1 ]
机构
[1] Indus Hosp & Hlth Network, Dept Internal Med, Karachi, Pakistan
[2] Indus Hosp & Hlth Network, Indus Hosp Res Ctr, Karachi, Pakistan
[3] Indus Hosp & Hlth Network, Dept Pharm Serv, Karachi, Pakistan
关键词
COVID-19; Remdesivir; mortality; ARDS;
D O I
10.12669/pjms.38.ICON-2022.5779
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: To see the difference in mortality among hospitalized COVID-19 patients given Remdesivir (RDV) with those who were not given RDV. Methods: A prospective cohort study was conducted on patients who were admitted to the COVID-19 isolation unit at The Indus Hospital, Korangi Campus Karachi between March and June 2020. Results: Groups were similar in age and gender distribution. RDV group was more hypoxic, had severe ARDS and needed higher Oxygen support compared to non-RDV group (p=0.000). Median SOFA score was 2 in RDV vs 5 in non-RDV (p=0.000). More than moderate COVID pneumonia was found in 92% of the RDV group while 89% of non-RDV group (p value=0.001). Median day of illness to administer Remdesivir was 10. There was no difference in mortality (45.5% in RDV vs 40.4% in non-RDV; p=0.4) between the two groups. Median length of hospital stay was 12 days (IQR=7.5-14.5) in RDV group compared to 10 days (IQR=6-14) in non-RDV group (p=0.009). Conclusion: RDV did not show any difference in in-hospital mortality in our patients. More patients had severe ARDS in the RDV group while patients in the non-RDV group had higher SOFA score and multi-organ failure. Length of stay was longer in patients receiving Remdesivir.
引用
收藏
页码:405 / 410
页数:6
相关论文
共 12 条
[1]  
Beigel JH, 2020, NEW ENGL J MED, V383, P1813, DOI [10.1056/NEJMoa2007764, 10.1056/NEJMc2022236]
[2]   Remdesivir for 5 or 10 Days in Patients with Severe Covid-19 [J].
Goldman, Jason D. ;
Lye, David C. B. ;
Hui, David S. ;
Marks, Kristen M. ;
Bruno, Raffaele ;
Montejano, Rocio ;
Spinner, Christoph D. ;
Galli, Massimo ;
Ahn, Mi-Young ;
Nahass, Ronald G. ;
Chen, Yao-Shen ;
SenGupta, Devi ;
Hyland, Robert H. ;
Osinusi, Anu O. ;
Cao, Huyen ;
Blair, Christiana ;
Wei, Xuelian ;
Gaggar, Anuj ;
Brainard, Diana M. ;
Towner, William J. ;
Munoz, Jose ;
Mullane, Kathleen M. ;
Marty, Francisco M. ;
Tashima, Karen T. ;
Diaz, George ;
Subramanian, Aruna .
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (19) :1827-1837
[3]  
GOP MoNHsrac, CLIN MAN GUID COVID
[4]   The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus [J].
Gordon, Calvin J. ;
Tchesnokov, Egor P. ;
Feng, Joy Y. ;
Porter, Danielle P. ;
Gotte, Matthias .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2020, 295 (15) :4773-4779
[5]  
Medicine UNLo, REMD COVID 19 2021
[6]   Repurposed Antiviral Drugs for Covid-19-Interim WHO Solidarity Trial Results [J].
Pan, Hongchao ;
Peto, Richard ;
Karim, Quarraisha Abdool ;
Alejandria, Marissa ;
Henao-Restrepo, Ana Maria ;
Garcia, Cesar Hernandez ;
Kieny, Marie Paule ;
Malekzadeh, Reza ;
Murthy, Srinivas ;
Preziosi, Marie-Pierre ;
Reddy, K. Srinath ;
Periago, Mirta Roses ;
Sathiyamoorthy, Vasee ;
Rottingen, John-Arne ;
Swaminathan, Soumya ;
Maggioni, Aldo ;
Babiker, Abdel ;
Cook, Deborah ;
Dondorp, Arjen ;
Kang, Gagandeep ;
Trelle, S. ;
McGinty, S. ;
Branca, M. ;
Appadoo, S. ;
Sterne, J. A. C. ;
Rogers, C. A. ;
Cappel-Porter, H. B. C. ;
Hutton, D. ;
Bellani, S. ;
Allum, E. ;
Kirwan, J. ;
Lydon, P. ;
Miranda-Montoya, M. C. ;
Salami, K. K. ;
Sathiyamoorthy, V. ;
Swaminathan, S. ;
Como, N. ;
Sinani, N. ;
Lopardo, G. ;
Periago, M. Roses ;
Nunes, E. P. ;
Reges, P. P. S. ;
Murthy, S. ;
Salvadori, M. ;
Alvarez-Moreno, C. A. ;
Rubio, M. L. Mesa ;
Hassany, M. ;
Zaid, H. ;
Tikkinen, K. A. O. ;
Perola, M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (06) :497-511
[7]   Remdesivir for treatment of COVID-19; an updated systematic review and meta-analysis [J].
Rezagholizadeh, Afra ;
Khiali, Sajad ;
Sarbakhsh, Parvin ;
Entezari-Maleki, Taher .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2021, 897
[8]   Determinants of in-hospital mortality in COVID-19; a prospective cohort study from Pakistan [J].
Sarfaraz, Samreen ;
Shaikh, Quratulain ;
Saleem, Syed Ghazanfar ;
Rahim, Anum ;
Herekar, Fivzia Farooq ;
Junejo, Samina ;
Hussain, Aneela .
PLOS ONE, 2021, 16 (05)
[9]   Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19 A Randomized Clinical Trial [J].
Spinner, Christoph D. ;
Gottlieb, Robert L. ;
Criner, Gerard J. ;
Arribas Lopez, Jose Ramon ;
Cattelan, Anna Maria ;
Soriano Viladomiu, Alex ;
Ogbuagu, Onyema ;
Malhotra, Prashant ;
Mullane, Kathleen M. ;
Castagna, Antonella ;
Chai, Louis Yi Ann ;
Roestenberg, Meta ;
Tsang, Owen Tak Yin ;
Bernasconi, Enos ;
Le Turnier, Paul ;
Chang, Shan-Chwen ;
SenGupta, Devi ;
Hyland, Robert H. ;
Osinusi, Anu O. ;
Cao, Huyen ;
Blair, Christiana ;
Wang, Hongyuan ;
Gaggar, Anuj ;
Brainard, Diana M. ;
McPhail, Mark J. ;
Bhagani, Sanjay ;
Ahn, Young ;
Sanyal, Arun J. ;
Huhn, Gregory ;
Marty, Francisco M. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 324 (11) :1048-1057
[10]   Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial [J].
Wang, Yeming ;
Zhang, Dingyu ;
Du, Guanhua ;
Du, Ronghui ;
Zhao, Jianping ;
Jin, Yang ;
Fu, Shouzhi ;
Gao, Ling ;
Cheng, Zhenshun ;
Lu, Qiaofa ;
Hu, Yi ;
Luo, Guangwei ;
Wang, Ke ;
Lu, Yang ;
Li, Huadong ;
Wang, Shuzhen ;
Ruan, Shunan ;
Yang, Chengqing ;
Mei, Chunlin ;
Wang, Yi ;
Ding, Dan ;
Wu, Feng ;
Tang, Xin ;
Ye, Xianzhi ;
Ye, Yingchun ;
Liu, Bing ;
Yang, Jie ;
Yin, Wen ;
Wang, Aili ;
Fan, Guohui ;
Zhou, Fei ;
Liu, Zhibo ;
Gu, Xiaoying ;
Xu, Jiuyang ;
Shang, Lianhan ;
Zhang, Yi ;
Cao, Lianjun ;
Guo, Tingting ;
Wan, Yan ;
Qin, Hong ;
Jiang, Yushen ;
Jaki, Thomas ;
Hayden, Frederick G. ;
Horby, Peter W. ;
Cao, Bin ;
Wang, Chen .
LANCET, 2020, 395 (10236) :1569-1578